Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) Stock Statistics & Valuation Metrics

Aarey Drugs & Pharmaceuticals Ltd. has a market cap or net worth of INR 2.99B. The enterprise value is INR 1.91B.

Market Cap

INR 2.99B

Enterprise Value

INR 1.91B

Aarey Drugs & Pharmaceuticals Ltd. has 28,354,303 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

28,354,303

Owned by Insiders

―

Owned by Institutions

―

Aarey Drugs & Pharmaceuticals Ltd.’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 1.57%.

Return on Equity (ROE)

0.03

Return on Assets (ROA)

0.01

Return on Invested Capital (ROIC)

1.57%

Return on Capital Employed (ROCE)

0.03

Revenue Per Employee

35.78M

Profits Per Employee

300.58K

Employee Count

132

Asset Turnover

1.59

Inventory Turnover

11.03

The current PE Ratio of Aarey Drugs & Pharmaceuticals Ltd. is 74.35. Aarey Drugs & Pharmaceuticals Ltd.’s PEG ratio is -110.03.

PE Ratio

74.35

PS Ratio

0.75

PB Ratio

2.07

Price to FCF

68.12

Price to Operating Cash Flow

21.29

PEG Ratio

-110.03

In the last 12 months, Aarey Drugs & Pharmaceuticals Ltd. had revenue of 4.72B and earned 39.68M in profits. Earnings per share was 1.39.

Revenue

4.72B

Gross Profit

141.50M

Operating Income

43.19M

Pretax Income

54.14M

Net Income

39.68M

EBITDA

132.69M

Earnings Per Share (EPS)

1.39

In the last 12 months, operating cash flow was 145.98M and capital expenditures -100.49M, giving a free cash flow of 45.49M billion.

Operating Cash Flow

145.98M

Free Cash Flow

45.49M

Free Cash Flow per Share

1.60

Aarey Drugs & Pharmaceuticals Ltd. pays an annual dividend of INR 0.10, resulting in a dividend yield of ―

Dividend Per Share

INR 0.10

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

1.47%

Earnings Yield

1.34%

Beta

1.36

52-Week Price Change

10.69%

50-Day Moving Average

101.02

200-Day Moving Average

83.29

Relative Strength Index (RSI)

55.10

Average Volume (3m)

11.99K

Aarey Drugs & Pharmaceuticals Ltd. upcoming earnings date is Nov 12, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 14, 2026

Next Earnings Date

Nov 12, 2026

Ex-Dividend Date

Dec 13, 2018

Aarey Drugs & Pharmaceuticals Ltd. as a current ratio of 1.81, with Debt / Equity ratio of 33.21%

Current Ratio

1.81

Quick Ratio

1.53

Debt to Market Cap

0.34

Net Debt to EBITDA

3.66

Interest Coverage Ratio

0.86

In the past 12 months, Aarey Drugs & Pharmaceuticals Ltd. has paid 14.47M in taxes.

Income Tax

14.47M

Effective Tax Rate

0.27

Aarey Drugs & Pharmaceuticals Ltd. EV to EBITDA ratio is 43.33, with an EV/FCF ratio of 68.18.

EV to Sales

0.75

EV to EBITDA

43.33

EV to Free Cash Flow

68.18

EV to Operating Cash Flow

21.24

Aarey Drugs & Pharmaceuticals Ltd. has INR 33.98M in cash and marketable securities with INR 0.00 in debt, giving a net cash position of INR 33.98M billion.

Cash & Marketable Securities

INR 33.98M

Total Debt

INR 0.00

Net Cash

INR 33.98M

Net Cash Per Share

INR 1.20

Tangible Book Value Per Share

INR 52.90

Gross margin is 2.86%, with operating margin of 0.86%, and net profit margin of 1.01%.

Gross Margin

2.86%

Operating Margin

0.86%

Pretax Margin

1.01%

Net Profit Margin

1.01%

EBITDA Margin

1.73%

EBIT Margin

0.95%

The average price target for Aarey Drugs & Pharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-7.69%

EPS Growth Forecast

-0.35%

Smart Score

―

AI Score

53